Prevalence and differences in the co-administration of drugs known to interact: an analysis of three distinct and large populations
Abstract Background The co-administration of drugs known to interact greatly impacts morbidity, mortality, and health economics. This study aims to examine the drug–drug interaction (DDI) phenomenon with a large-scale longitudinal analysis of age and gender differences found in drug administration d...
Main Authors: | Jon Sánchez-Valle, Rion Brattig Correia, Marta Camacho-Artacho, Rosalba Lepore, Mauro M. Mattos, Luis M. Rocha, Alfonso Valencia |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2024-04-01
|
Series: | BMC Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12916-024-03384-1 |
Similar Items
-
Anti-hypertensive drugs deprescribing: an updated systematic review of clinical trials
by: Salvatore Crisafulli, et al.
Published: (2021-10-01) -
Medication-Related Problems in Older People with Multimorbidity in Catalonia: A Real-World Data Study with 5 Years’ Follow-Up
by: Amelia Troncoso-Mariño, et al.
Published: (2021-02-01) -
Polypharmacy in the Management of Arterial Hypertension—Friend or Foe?
by: Camelia Cristina Diaconu, et al.
Published: (2021-11-01) -
The (Mis)use of Psychotropic Drugs and Addiction to Anxiolytics among Older Adults Living at Home or in Retirement Homes: Implications for Quality of Life
by: Mirjana Kralj, et al.
Published: (2023-11-01) -
Polypharmacy in Type 2 Diabetes Mellitus: Insights from an Internal Medicine Department
by: Elena-Codruța Dobrică, et al.
Published: (2019-08-01)